What This Looks Like at bStrong Members on Ozempic, Wegovy, Mounjaro, and Zepbound train with us regularly at both our Bellevue and Redmond locations
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
9, 2026 at 4:40 PM CDT TYLER, Texas (KLTV) - Dr
US Judge Sides with FDAs Removal of Lillys Weight Loss Drug from Shortage List (May 2025) PMC/NCBI
This might allow fine-tuning the benefit-to-side-effect ratio
Venoms from both land and sea creatures provide a rich source of medicinal compounds